We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+16.03%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$3.11B
AUM Growth
+$364M
Cap. Flow
+$33.6M
Cap. Flow %
1.08%
Top 10 Hldgs %
20.36%
Holding
317
New
24
Increased
113
Reduced
139
Closed
27

Sector Composition

Rank Sector Weight
1 Healthcare 22.48%
2 Industrials 19.28%
3 Technology 19.21%
4 Communication Services 10.31%
5 Consumer Discretionary 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPLN
51
Openlane
OPLN
$4.54B
$19M 0.61%
979,141
+110,533
+13% +$2.08M
AJRD
52
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$19M 0.61%
534,636
+46,991
+10% +$1.73M
WLDN icon
53
Willdan Group
WLDN
$1.3B
$18.8M 0.61%
507,745
+267,081
+111% +$9.5M
PBH icon
54
Prestige Consumer Healthcare
PBH
$2.6B
$18.6M 0.6%
620,963
+19,734
+3% +$566K
CHX
55
DELISTED
ChampionX
CHX
$18.5M 0.6%
450,833
-24,945
-5% -$922K
VRNT
56
DELISTED
Verint Systems
VRNT
$18.3M 0.59%
601,210
-34,812
-5% -$885K
COLL icon
57
Collegium Pharmaceutical
COLL
$956M
$18M 0.58%
1,191,141
+259,015
+28% +$4.15M
FIVE icon
58
Five Below
FIVE
$13.5B
$18M 0.58%
145,021
-8,498
-6% -$1.03M
AAN.A
59
DELISTED
The Aaron's Company Inc Class A
AAN.A
$17.9M 0.58%
340,466
-109,448
-24% -$5.76M
TDC icon
60
Teradata
TDC
$2.55B
$17.8M 0.57%
408,385
+101,509
+33% +$4.56M
PCRX icon
61
Pacira BioSciences
PCRX
$997M
$17.7M 0.57%
464,040
+12,213
+3% +$477K
ENSG icon
62
The Ensign Group
ENSG
$10.7B
$17.5M 0.56%
365,952
-22,123
-6% -$967K
MED icon
63
Medifast
MED
$141M
$17.4M 0.56%
136,531
+87,262
+177% +$11.1M
EHC icon
64
Encompass Health
EHC
$12.4B
$17.1M 0.55%
367,122
+88,201
+32% +$4.47M
SHOO icon
65
Steven Madden
SHOO
$3.55B
$17M 0.55%
503,128
-29,882
-6% -$977K
AZTA icon
66
Azenta
AZTA
$1.48B
$16.7M 0.54%
569,323
-33,775
-6% -$1.02M
CRS icon
67
Carpenter Technology
CRS
$28.4B
$16.3M 0.53%
356,238
-4,889
-1% -$218K
AVNS
68
DELISTED
Avanos Medical
AVNS
$16.2M 0.52%
+380,006
New +$17M
SRI icon
69
Stoneridge
SRI
$213M
$16M 0.51%
553,295
+177,242
+47% +$4.85M
CUB
70
DELISTED
Cubic Corporation
CUB
$15.9M 0.51%
282,593
+123,930
+78% +$7.32M
CMCO icon
71
Columbus McKinnon
CMCO
$584M
$15.9M 0.51%
461,826
-26,485
-5% -$922K
MRCY icon
72
Mercury Systems
MRCY
$6.52B
$15.9M 0.51%
247,458
-97,469
-28% -$5.62M
PTC icon
73
PTC
PTC
$16B
$15.8M 0.51%
171,109
+13,636
+9% +$1.21M
SIX
74
DELISTED
Six Flags Entertainment Corp.
SIX
$15.4M 0.5%
311,971
+26,221
+9% +$1.48M
GMED icon
75
Globus Medical
GMED
$11.2B
$15.4M 0.5%
311,342
+20,171
+7% +$912K

Similar funds

Rice Hall James & Associates's Q1 2019 Portfolio in Review

As of Q1 2019, Rice Hall James & Associates held 317 positions worth $3.11B, up 13% from $2.74B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Rice Hall James & Associates's Q1 2019 filing shows 24 new, 113 increased, 139 reduced and 27 closed positions. Its largest new stake was Vonage Holdings Corporation: 2,004,892 shares worth $20.1M. The largest sale was Integrated Device Technology I, an estimated $59.8M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Industrials and Technology.

  • Rice Hall James & Associates's largest Q1 2019 buy was Vonage Holdings Corporation: 2,004,892 shares worth $20.1M.
  • Rice Hall James & Associates added most to Euronet Worldwide in Q1 2019, an estimated $26M increase.
  • Rice Hall James & Associates's biggest Q1 2019 reduction was iShares Russell 2000 Growth ETF, cutting an estimated $17.4M.
  • Rice Hall James & Associates fully exited Integrated Device Technology I in Q1 2019, selling an estimated $59.8M.
  • Rice Hall James & Associates's ten largest holdings make up 20% of its $3.11B portfolio in Q1 2019.
  • Rice Hall James & Associates opened 24 new positions and closed 27 in Q1 2019.
  • Rice Hall James & Associates's portfolio value rose 13% quarter-over-quarter to $3.11B.

Based on Rice Hall James & Associates's 13F filing for Q1 2019, filed 1 May 2019.